Recursion Enhances its Leadership Team and Deepens Focus on Neuroscience with Three Senior Appointments
SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug d…
